Literatur
COLIPA–Empfehlung Nr. 13: Anwendungshinweise bei Sonnenschutzmitteln. Deutsche Übersetzung/IKW, März 2004
The SCCNFP’S Notes of Guidance for Testing of Cosmetic Ingredients and their Safety Evaluation, 5th Revision, Okt 2003, Auszug, S 72–78
Dubbert W (2004) Nanotechnologie – Risiken oder Chancen? UMID März UBA, Berlin, S 16–19
Possible adverse health, environmental and safety impacts: Nanoscience and nanotechnologies, July 2004, S 35–50
Oberdörster G et al. (2004) Tanslocation of inhalated ultrafine particles to the brain. Inhalation Toxicol 16: 437–445
SCCP (2005) Request for a scientific opinion: safety of nanomaterials in cosmetic products
SCCNFP/0649/03: Opinion concerning ZINC OXIDE, Colipa n0 S 76, Adopted by the SCCNFP during the 24th plenary meeting of 24–25 June 2003
Weigmann HJ, Lademann J, Pelchrzim R v. et al. (2000) Quantitative Bestimmung des Penetrationsverhaltens von Sonnenschutz- und Arzneimitteln in Relation zum realen Hornschichtprofil. Akt Dermatol 26: 138–141
Lademann J, Weigmann HJ, Rickmeyer C et al. (1999) Penetration of titanium dioxide. Skin Pharmacol Appl Skin Physiol 12: 47–256
Lademann J, Otberg N, Richter H et al. (2003) Follikuläre Penetration. Hautarzt 54: 321–323
Hostynek J, Maibach H (2002) Tin, zinc and selenium: metals in cosmetics and personal care products. Cosmetics Toiletries Magazine 117(9)
SCCNFP: Opinion concerning Ketoconazole adopted by the Scientific Committee on Cosmetic Products and Non-Food Products intended for Consumers during the plenary of 23 June 1999
SCCNFP/0601/02, final: Opinion concerning Ketoconazole, adopted by the SCCNFP during the 21th Plenary Meeting of 17 September 2002
SCCNFP/0706/03, final, Opinion of the Scientific Committee on Cosmetic Products and Non-Food Products intended for Consumers concerning azole antimycotic resistance, adopted by the SCCNFP during the 24th Plenary Meeting of 24–25 June 2003
05/ENTR/COS/27: Ketoconazole Request from DG Enterprise for a CHMP Opinion on various questions, CHMP Report, London, Doc.Ref.: EMEA/CHMP/62096/2005, 17 February 2005
Problematik der Entwicklung von Resistenzen humaner Mykosen gegenüber Azol-Antimykotika und eventueller Wechselwirkungen mit den als Fungizid eingesetzten Pflanzenschutzmitteln, Bericht des BgVV vom 7.6.2001, http://www.bfr.bund.de/cm/218/problematik_der_entwicklung_von_resistenzen_humaner_mykosen_gegenueber_azol_antimykotika.pdf
Gebhardt M, Geier J et al. (1996) Kontaktallergie auf Prothesenkunststoffe und Differentialdiagnostik der Prothesenintoleranz. Dtsch Zahnärztl Z 51: 395–397
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schulz, C. 69. und 70. Sitzung der vorläufigen Kommission für kosmetische Mittel am 18. November 2004 und 28. April 2005 in Berlin. Bundesgesundheitsbl. 49, 687–692 (2006). https://doi.org/10.1007/s00103-006-1289-5
Issue Date:
DOI: https://doi.org/10.1007/s00103-006-1289-5